Patrick Donnelly
Stock Analyst at Citigroup
(3.78)
# 720
Out of 5,090 analysts
351
Total ratings
53.72%
Success rate
6.97%
Average return
Main Sectors:
Stocks Rated by Patrick Donnelly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Buy | $165 → $185 | $145.49 | +27.16% | 27 | Nov 25, 2025 | |
| MTD Mettler-Toledo International | Maintains: Buy | $1,600 → $1,700 | $1,414.86 | +20.15% | 15 | Nov 10, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Buy | $350 → $375 | $317.69 | +18.04% | 17 | Oct 30, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Buy | $350 → $375 | $317.05 | +18.28% | 17 | Oct 30, 2025 | |
| GH Guardant Health | Maintains: Buy | $65 → $100 | $102.02 | -1.98% | 10 | Oct 30, 2025 | |
| IQV IQVIA Holdings | Maintains: Neutral | $200 → $230 | $225.85 | +1.84% | 13 | Oct 29, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Neutral | $500 → $580 | $572.77 | +1.26% | 20 | Oct 23, 2025 | |
| QDEL QuidelOrtho | Downgrades: Neutral | $40 → $33 | $27.76 | +18.88% | 6 | Oct 7, 2025 | |
| ICLR ICON Public Limited Company | Downgrades: Neutral | $225 → $200 | $185.80 | +7.64% | 10 | Aug 21, 2025 | |
| TECH Bio-Techne | Upgrades: Buy | $55 → $70 | $61.68 | +13.49% | 12 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $42 | $28.86 | +45.53% | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $40 → $38 | $48.03 | -20.88% | 17 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $150 → $200 | $184.31 | +8.51% | 21 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $60 → $80 | $74.97 | +6.71% | 15 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $85 → $80 | $128.96 | -37.97% | 17 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $17.77 | -15.59% | 12 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $22 → $18 | $10.93 | +64.68% | 8 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $185 | $182.51 | +1.36% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $265 | $226.25 | +17.13% | 12 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $23 | $14.24 | +61.52% | 4 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $20 | $16.75 | +19.40% | 3 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $101.06 | -25.79% | 13 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $28 | $22.11 | +26.64% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $145 | $100.79 | +43.86% | 1 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $62 | $47.01 | +31.46% | 13 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $265 → $300 | $394.81 | -24.01% | 24 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $2.49 | +261.45% | 6 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.75 → $2.75 | $3.08 | -10.71% | 4 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $250 → $260 | $258.39 | +0.62% | 11 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $9.56 | -37.24% | 4 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $28 → $32 | $7.09 | +351.34% | 2 | Nov 30, 2018 |
Agilent Technologies
Nov 25, 2025
Maintains: Buy
Price Target: $165 → $185
Current: $145.49
Upside: +27.16%
Mettler-Toledo International
Nov 10, 2025
Maintains: Buy
Price Target: $1,600 → $1,700
Current: $1,414.86
Upside: +20.15%
Bio-Rad Laboratories
Oct 30, 2025
Maintains: Buy
Price Target: $350 → $375
Current: $317.69
Upside: +18.04%
Bio-Rad Laboratories
Oct 30, 2025
Maintains: Buy
Price Target: $350 → $375
Current: $317.05
Upside: +18.28%
Guardant Health
Oct 30, 2025
Maintains: Buy
Price Target: $65 → $100
Current: $102.02
Upside: -1.98%
IQVIA Holdings
Oct 29, 2025
Maintains: Neutral
Price Target: $200 → $230
Current: $225.85
Upside: +1.84%
Thermo Fisher Scientific
Oct 23, 2025
Maintains: Neutral
Price Target: $500 → $580
Current: $572.77
Upside: +1.26%
QuidelOrtho
Oct 7, 2025
Downgrades: Neutral
Price Target: $40 → $33
Current: $27.76
Upside: +18.88%
ICON Public Limited Company
Aug 21, 2025
Downgrades: Neutral
Price Target: $225 → $200
Current: $185.80
Upside: +7.64%
Bio-Techne
Aug 21, 2025
Upgrades: Buy
Price Target: $55 → $70
Current: $61.68
Upside: +13.49%
Aug 13, 2025
Maintains: Buy
Price Target: $34 → $42
Current: $28.86
Upside: +45.53%
Aug 4, 2025
Maintains: Neutral
Price Target: $40 → $38
Current: $48.03
Upside: -20.88%
Jul 9, 2025
Upgrades: Buy
Price Target: $150 → $200
Current: $184.31
Upside: +8.51%
Jul 9, 2025
Upgrades: Buy
Price Target: $60 → $80
Current: $74.97
Upside: +6.71%
Jul 9, 2025
Downgrades: Sell
Price Target: $85 → $80
Current: $128.96
Upside: -37.97%
Mar 4, 2025
Maintains: Buy
Price Target: $20 → $15
Current: $17.77
Upside: -15.59%
Mar 4, 2025
Maintains: Neutral
Price Target: $22 → $18
Current: $10.93
Upside: +64.68%
Mar 4, 2025
Downgrades: Neutral
Price Target: $185
Current: $182.51
Upside: +1.36%
Jan 30, 2025
Maintains: Buy
Price Target: $285 → $265
Current: $226.25
Upside: +17.13%
Dec 11, 2024
Downgrades: Neutral
Price Target: $30 → $23
Current: $14.24
Upside: +61.52%
Nov 6, 2024
Maintains: Buy
Price Target: $18 → $20
Current: $16.75
Upside: +19.40%
Nov 6, 2024
Maintains: Buy
Price Target: $80 → $75
Current: $101.06
Upside: -25.79%
Aug 7, 2024
Maintains: Buy
Price Target: $30 → $28
Current: $22.11
Upside: +26.64%
Jul 30, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $100.79
Upside: +43.86%
Feb 8, 2024
Maintains: Buy
Price Target: $64 → $62
Current: $47.01
Upside: +31.46%
Dec 11, 2023
Maintains: Neutral
Price Target: $265 → $300
Current: $394.81
Upside: -24.01%
Dec 11, 2023
Maintains: Buy
Price Target: $7 → $9
Current: $2.49
Upside: +261.45%
Aug 10, 2023
Maintains: Neutral
Price Target: $3.75 → $2.75
Current: $3.08
Upside: -10.71%
Feb 17, 2023
Maintains: Neutral
Price Target: $250 → $260
Current: $258.39
Upside: +0.62%
Nov 3, 2022
Maintains: Buy
Price Target: $8 → $6
Current: $9.56
Upside: -37.24%
Nov 30, 2018
Upgrades: Neutral
Price Target: $28 → $32
Current: $7.09
Upside: +351.34%